Demographic and clinical variables | NIDCM group (n = 95) |
---|---|
Age, years | 49.7 ± 10.5 |
Male, n (%) | 66 (69.5) |
BMI, kg/m2 | 29.0 ± 5.8 |
Systolic blood pressure, mmHg | 126.0 ± 13.3 |
Heart rate, bpm | 79.1 ± 17.3 |
QRS duration, ms | 119.1 ± 29.9 |
NYHA class, n (%) I II III IV | 3 (3.2) 25 (26.3) 56 (58.9) 11 (11.6) |
VT, n (%) | 27 (28.4) |
Cardiovascular risk factors, n (%) | |
Arterial hypertension | 36 (37.9) |
Dyslipidemia | 45 (41.3) |
Diabetes | 8 (7.3) |
Smoker | 44 (40.4) |
Obesity | 70 (64.2) |
AF | 37 (38.9) |
Pharmacotherapy (at baseline), n (%) | |
ACE-I/ARB | 43 (39.4) |
Betablocker | 51 (46,7) |
CCB | 28 (25.6) |
Aldosterone antagonist | 9 (8.2) |
Statins | 20 (18.3) |
Diuretic | 3 (2.7) |
Laboratory values | |
BNP, ng/l | 1385.2 ± 986.9 |
TnI, ng/l | 0.2 ± 0.3 |
hs-CRP, mg/l | 3.0 ± 2.7 |
CRP, mg/l | 9.0 ± 5.7 |
NLR | 3.1 ± 3.0 |
ST2, pg/ml | 49.9 ± 80.3 |